Woods Jon B, Schmitt Clare K, Darnell Stephen C, Meysick Karen C, O'Brien Alison D
Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799, USA.
J Infect Dis. 2002 Feb 15;185(4):550-4. doi: 10.1086/338633. Epub 2002 Jan 22.
Ferrets were evaluated as a possible small animal model for the development of colitis and/or signs of the hemolytic uremic syndrome after oral infection with Escherichia coli O157:H7 or other Shiga toxin--producing E. coli (STEC). Ferrets treated with streptomycin (Stm) had higher counts of E. coli O157:H7 strain 86-24 Stm-resistant (Stm(r)) or O91:H21 strain B2F1 Stm(r) in their stools than non--Stm-treated animals. None of the animals displayed evidence of colitis, but Stm-treated animals fed strain 86-24 Stm(r) exhibited weight loss significantly greater than that exhibited by ferrets fed an isogenic mutant negative for the adhesin intimin. Moreover, 11 (23%) of the 47 Stm-treated ferrets inoculated with 86-24 Stm(r) or B2F1 Stm(r) developed hematuria and/or histological damage to glomeruli or thrombocytopenia, compared with 0 of 14 uninfected control animals receiving Stm in water. Thus, the ferret may serve as a model for renal disease secondary to intestinal infection with STEC.
雪貂被评估为一种可能的小动物模型,用于研究口服感染大肠杆菌O157:H7或其他产志贺毒素大肠杆菌(STEC)后结肠炎的发展和/或溶血尿毒综合征的症状。用链霉素(Stm)治疗的雪貂粪便中大肠杆菌O157:H7菌株86 - 24链霉素抗性(Stm(r))或O91:H21菌株B2F1 Stm(r)的数量高于未用Stm治疗的动物。没有动物表现出结肠炎的迹象,但喂食86 - 24 Stm(r)菌株的Stm治疗动物体重减轻明显大于喂食缺乏黏附素intimin的同基因突变体的雪貂。此外,接种86 - 24 Stm(r)或B2F1 Stm(r)的47只Stm治疗雪貂中有11只(23%)出现血尿和/或肾小球组织学损伤或血小板减少,而14只饮用含Stm水的未感染对照动物中无一出现上述情况。因此,雪貂可作为STEC肠道感染继发肾病的模型。